目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Disease
1.2.2. Technology
1.2.3. Specialty
1.2.4. End use
1.2.5. Regional scope
1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Disease
2.2.2. Technology
2.2.3. Specialty
2.2.4. End use
2.2.5. Regional outlook
2.3. Competitive Insights

Chapter 3. Rare Disease Genetic Testing Market Variables; Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Expanding patient registry for rare disease
3.2.1.2. Declining sequencing cost
3.2.1.3. Technological advancements in disease diagnosis
3.2.1.4. Launch of programs & new product development in rare disease diagnosis
3.2.2. Market restraint analysis
3.2.2.1. Absence of effective diagnosis framework
3.2.2.2. Technical challenges associated with genetic tests & data management
3.3. Rare Disease Genetic Testing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Pricing Analysis

Chapter 4. Rare Disease Genetic Testing Market: Disease Estimates & Trend Analysis
4.1. Global Rare Disease Genetic Testing Market: Disease Dashboard
4.2. Global Rare Disease Genetic Testing Market: Disease Movement Analysis
4.3. Global Rare Disease Genetic Testing Market by Disease; Revenue
4.4. Neurological Disorders
4.4.1. Neurological Disorders market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Immunological Disorders
4.5.1. Immunological Disorders market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Hematology Diseases
4.6.1. Hematology Diseases market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Endocrine & Metabolism Diseases
4.7.1. Endocrine & Metabolism Diseases market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Cancer
4.8.1. Cancer market estimates and forecasts 2018 to 2030 (USD Million)
4.9. Musculoskeletal Disorders
4.9.1. Musculoskeletal Disorders market estimates and forecasts 2018 to 2030 (USD Million)
4.10. Cardiovascular Disorders
4.10.1. Cardiovascular Disorders market estimates and forecasts 2018 to 2030 (USD Million)
4.11. Dermatology Diseases
4.11.1. Dermatology Diseases market estimates and forecasts 2018 to 2030 (USD Million)
4.12. Other Rare Diseases
4.12.1. Other Rare Diseases market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Rare Disease Genetic Testing Market: Technology Estimates & Trend Analysis
5.1. Global Rare Disease Genetic Testing Market: Technology Dashboard
5.2. Global Rare Disease Genetic Testing Market: Technology Movement Analysis
5.3. Global Rare Disease Genetic Testing Market by Technology; Revenue
5.4. Next-Generation Sequencing (NGS)
5.4.1. Next-Generation Sequencing (NGS) market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Whole Exome Sequencing
5.4.2.1. Whole Exome Sequencing market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Whole Genome Sequencing
5.4.3.1. Whole Genome Sequencing market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Array Technology
5.5.1. Array Technology market estimates and forecasts 2018 to 2030 (USD Million)
5.6. FISH
5.6.1. FISH market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Sanger Sequencing
5.7.1. Sanger Sequencing market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Karyotyping
5.8.1. Karyotyping market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Rare Disease Genetic Testing Market: Specialty Estimates & Trend Analysis
6.1. Global Rare Disease Genetic Testing Market: Specialty Dashboard
6.2. Global Rare Disease Genetic Testing Market: Specialty Movement Analysis
6.3. Global Rare Disease Genetic Testing Market by Specialty; Revenue
6.4. Molecular Genetic Tests
6.4.1. Molecular Genetic Tests market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Chromosomal Genetic Tests
6.5.1. Chromosomal Genetic Tests market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Biochemical Genetic Tests
6.6.1. Biochemical Genetic Tests market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Rare Disease Genetic Testing Market: Regional Estimates & Trend Analysis by Disease; Technology; Specialty; End use and Methodology
7.1. Regional Dashboard
7.2. Market Size; & Forecasts Trend Analysis; 2018 to 2030:
7.3. North America
7.3.1. U.S.
7.3.1.1. Key country dynamics
7.3.1.2. Regulatory framework/ reimbursement structure
7.3.1.3. Competitive scenario
7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.3.2. Canada
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/ reimbursement structure
7.3.2.3. Competitive scenario
7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.3.3. Mexico
7.3.3.1. Key country dynamics
7.3.3.2. Regulatory framework/ reimbursement structure
7.3.3.3. Competitive scenario
7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework/ reimbursement structure
7.4.1.3. Competitive scenario
7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. Germany
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. France
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.4.4. Italy
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive scenario
7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.4.5. Spain
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/ reimbursement structure
7.4.5.3. Competitive scenario
7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.4.6. Norway
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/ reimbursement structure
7.4.6.3. Competitive scenario
7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/ reimbursement structure
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.4.8. Denmark
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/ reimbursement structure
7.4.8.3. Competitive scenario
7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. India
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.5.4. Australia
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.5.5. South Korea
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Argentina
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. UAE
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Kuwait
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis; By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis; 2024
8.3.4. Quest Diagnostics Inc.
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Centogene N.V.
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Invitae Corp.
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. F. Hoffmann-La Roche Ltd
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Arup Laboratories
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Eurofins Scientific
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Strand Life Sciences
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Ambry Genetics
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Perkin Elmer; Inc.
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Realm IDX; Inc.
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives

List of Tables
Table 1 List of abbreviations
Table 2 North America Rare diseases genetic testing market; by region; 2018 - 2030 (USD Million)
Table 3 North America Rare diseases genetic testing market; by disease; 2018 - 2030 (USD Million)
Table 4 North America Rare diseases genetic testing market; by technology; 2018 - 2030 (USD Million)
Table 5 North America Rare diseases genetic testing market; by specialty; 2018 - 2030 (USD Million)
Table 6 North America Rare diseases genetic testing market; by end use; 2018 - 2030 (USD Million)
Table 7 U.S Rare diseases genetic testing market; by disease; 2018 - 2030 (USD Million)
Table 8 U.S Rare diseases genetic testing market; by technology; 2018 - 2030 (USD Million)
Table 9 U.S Rare diseases genetic testing market; by specialty; 2018 - 2030 (USD Million)
Table 10 U.S Rare diseases genetic testing market; by end use; 2018 - 2030 (USD Million)
Table 11 Canada Rare diseases genetic testing market; by disease; 2018 - 2030 (USD Million)
Table 12 Canada Rare diseases genetic testing market; by technology; 2018 - 2030 (USD Million)
Table 13 Canada Rare diseases genetic testing market; by specialty; 2018 - 2030 (USD Million)
Table 14 Canada Rare diseases genetic testing market; by end use; 2018 - 2030 (USD Million)
Table 15 Mexico Rare diseases genetic testing market; by disease; 2018 - 2030 (USD Million)
Table 16 Mexico Rare diseases genetic testing market; by technology; 2018 - 2030 (USD Million)
Table 17 Mexico Rare diseases genetic testing market; by specialty; 2018 - 2030 (USD Million)
Table 18 Mexico Rare diseases genetic testing market; by end use; 2018 - 2030 (USD Million)
Table 19 Europe Rare diseases genetic testing market; by disease; 2018 - 2030 (USD Million)
Table 20 Europe Rare diseases genetic testing market; by technology; 2018 - 2030 (USD Million)
Table 21 Europe Rare diseases genetic testing market; by specialty; 2018 - 2030 (USD Million)
Table 22 Europe Rare diseases genetic testing market; by end use; 2018 - 2030 (USD Million)
Table 23 UK Rare diseases genetic testing market; by disease; 2018 - 2030 (USD Million)
Table 24 UK Rare diseases genetic testing market; by technology; 2018 - 2030 (USD Million)
Table 25 UK Rare diseases genetic testing market; by specialty; 2018 - 2030 (USD Million)
Table 26 UK Rare diseases genetic testing market; by end use; 2018 - 2030 (USD Million)
Table 27 Germany Rare diseases genetic testing market; by disease; 2018 - 2030 (USD Million)
Table 28 Germany Rare diseases genetic testing market; by technology; 2018 - 2030 (USD Million)
Table 29 Germany Rare diseases genetic testing market; by specialty; 2018 - 2030 (USD Million)
Table 30 Germany Rare diseases genetic testing market; by end use; 2018 - 2030 (USD Million)
Table 31 France Rare diseases genetic testing market; by disease; 2018 - 2030 (USD Million)
Table 32 France Rare diseases genetic testing market; by technology; 2018 - 2030 (USD Million)
Table 33 France Rare diseases genetic testing market; by specialty; 2018 - 2030 (USD Million)
Table 34 France Rare diseases genetic testing market; by end use; 2018 - 2030 (USD Million)
Table 35 Italy Rare diseases genetic testing market; by disease; 2018 - 2030 (USD Million)
Table 36 Italy Rare diseases genetic testing market; by technology; 2018 - 2030 (USD Million)
Table 37 Italy Rare diseases genetic testing market; by specialty; 2018 - 2030 (USD Million)
Table 38 Italy Rare diseases genetic testing market; by end use; 2018 - 2030 (USD Million)
Table 39 Spain Rare diseases genetic testing market; by disease; 2018 - 2030 (USD Million)
Table 40 Spain Rare diseases genetic testing market; by technology; 2018 - 2030 (USD Million)
Table 41 Spain Rare diseases genetic testing market; by specialty; 2018 - 2030 (USD Million)
Table 42 Spain Rare diseases genetic testing market; by end use; 2018 - 2030 (USD Million)
Table 43 Denmark Rare diseases genetic testing market; by disease; 2018 - 2030 (USD Million)
Table 44 Denmark Rare diseases genetic testing market; by technology; 2018 - 2030 (USD Million)
Table 45 Denmark Rare diseases genetic testing market; by specialty; 2018 - 2030 (USD Million)
Table 46 Denmark Rare diseases genetic testing market; by end use; 2018 - 2030 (USD Million)
Table 47 Sweden Rare diseases genetic testing market; by disease; 2018 - 2030 (USD Million)
Table 48 Sweden Rare diseases genetic testing market; by technology; 2018 - 2030 (USD Million)
Table 49 Sweden Rare diseases genetic testing market; by specialty; 2018 - 2030 (USD Million)
Table 50 Sweden Rare diseases genetic testing market; by end use; 2018 - 2030 (USD Million)
Table 51 Norway Rare diseases genetic testing market; by disease; 2018 - 2030 (USD Million)
Table 52 Norway Rare diseases genetic testing market; by technology; 2018 - 2030 (USD Million)
Table 53 Norway Rare diseases genetic testing market; by specialty; 2018 - 2030 (USD Million)
Table 54 Norway Rare diseases genetic testing market; by end use; 2018 - 2030 (USD Million)
Table 55 Asia Pacific Rare diseases genetic testing market; by disease; 2018 - 2030 (USD Million)
Table 56 Asia Pacific Rare diseases genetic testing market; by technology; 2018 - 2030 (USD Million)
Table 57 Asia Pacific Rare diseases genetic testing market; by specialty; 2018 - 2030 (USD Million)
Table 58 Asia Pacific Rare diseases genetic testing market; by end use; 2018 - 2030 (USD Million)
Table 59 Japan Rare diseases genetic testing market; by disease; 2018 - 2030 (USD Million)
Table 60 Japan Rare diseases genetic testing market; by technology; 2018 - 2030 (USD Million)
Table 61 Japan Rare diseases genetic testing market; by specialty; 2018 - 2030 (USD Million)
Table 62 Japan Rare diseases genetic testing market; by end use; 2018 - 2030 (USD Million)
Table 63 China Rare diseases genetic testing market; by disease; 2018 - 2030 (USD Million)
Table 64 China Rare diseases genetic testing market; by technology; 2018 - 2030 (USD Million)
Table 65 China Rare diseases genetic testing market; by specialty; 2018 - 2030 (USD Million)
Table 66 China Rare diseases genetic testing market; by end use; 2018 - 2030 (USD Million)
Table 67 India Rare diseases genetic testing market; by disease; 2018 - 2030 (USD Million)
Table 68 India Rare diseases genetic testing market; by technology; 2018 - 2030 (USD Million)
Table 69 India Rare diseases genetic testing market; by specialty; 2018 - 2030 (USD Million)
Table 70 India Rare diseases genetic testing market; by end use; 2018 - 2030 (USD Million)
Table 71 Australia Rare diseases genetic testing market; by disease; 2018 - 2030 (USD Million)
Table 72 Australia Rare diseases genetic testing market; by technology; 2018 - 2030 (USD Million)
Table 73 Australia Rare diseases genetic testing market; by specialty; 2018 - 2030 (USD Million)
Table 74 Australia Rare diseases genetic testing market; by end use; 2018 - 2030 (USD Million)
Table 75 South Korea Rare diseases genetic testing market; by disease; 2018 - 2030 (USD Million)
Table 76 South Korea Rare diseases genetic testing market; by technology; 2018 - 2030 (USD Million)
Table 77 South Korea Rare diseases genetic testing market; by specialty; 2018 - 2030 (USD Million)
Table 78 South Korea Rare diseases genetic testing market; by end use; 2018 - 2030 (USD Million)
Table 79 Thailand Rare diseases genetic testing market; by disease; 2018 - 2030 (USD Million)
Table 80 Thailand Rare diseases genetic testing market; by technology; 2018 - 2030 (USD Million)
Table 81 Thailand Rare diseases genetic testing market; by specialty; 2018 - 2030 (USD Million)
Table 82 Thailand Rare diseases genetic testing market; by end use; 2018 - 2030 (USD Million)
Table 83 Latin America Rare diseases genetic testing market; by disease; 2018 - 2030 (USD Million)
Table 84 Latin America Rare diseases genetic testing market; by technology; 2018 - 2030 (USD Million)
Table 85 Latin America Rare diseases genetic testing market; by specialty; 2018 - 2030 (USD Million)
Table 86 Latin America Rare diseases genetic testing market; by end use; 2018 - 2030 (USD Million)
Table 87 Brazil Rare diseases genetic testing market; by disease; 2018 - 2030 (USD Million)
Table 88 Brazil Rare diseases genetic testing market; by technology; 2018 - 2030 (USD Million)
Table 89 Brazil Rare diseases genetic testing market; by specialty; 2018 - 2030 (USD Million)
Table 90 Brazil Rare diseases genetic testing market; by end use; 2018 - 2030 (USD Million)
Table 91 Argentina Rare diseases genetic testing market; by disease; 2018 - 2030 (USD Million)
Table 92 Argentina Rare diseases genetic testing market; by technology; 2018 - 2030 (USD Million)
Table 93 Argentina Rare diseases genetic testing market; by specialty; 2018 - 2030 (USD Million)
Table 94 Argentina Rare diseases genetic testing market; by end use; 2018 - 2030 (USD Million)
Table 95 MEA Rare diseases genetic testing market; by disease; 2018 - 2030 (USD Million)
Table 96 MEA Rare diseases genetic testing market; by technology; 2018 - 2030 (USD Million)
Table 97 MEA Rare diseases genetic testing market; by specialty; 2018 - 2030 (USD Million)
Table 98 MEA Rare diseases genetic testing market; by end use; 2018 - 2030 (USD Million)
Table 99 South Africa Rare diseases genetic testing market; by disease; 2018 - 2030 (USD Million)
Table 100 South Africa Rare diseases genetic testing market; by technology; 2018 - 2030 (USD Million)
Table 101 South Africa Rare diseases genetic testing market; by specialty; 2018 - 2030 (USD Million)
Table 102 South Africa Rare diseases genetic testing market; by end use; 2018 - 2030 (USD Million)
Table 103 Saudi Arabia Rare diseases genetic testing market; by disease; 2018 - 2030 (USD Million)
Table 104 Saudi Arabia Rare diseases genetic testing market; by technology; 2018 - 2030 (USD Million)
Table 105 Saudi Arabia Rare diseases genetic testing market; by specialty; 2018 - 2030 (USD Million)
Table 106 Saudi Arabia Rare diseases genetic testing market; by end use; 2018 - 2030 (USD Million)
Table 107 UAE Rare diseases genetic testing market; by disease; 2018 - 2030 (USD Million)
Table 108 UAE Rare diseases genetic testing market; by technology; 2018 - 2030 (USD Million)
Table 109 UAE Rare diseases genetic testing market; by specialty; 2018 - 2030 (USD Million)
Table 110 UAE Rare diseases genetic testing market; by end use; 2018 - 2030 (USD Million)
Table 111 Kuwait Rare diseases genetic testing market; by disease; 2018 - 2030 (USD Million)
Table 112 Kuwait Rare diseases genetic testing market; by technology; 2018 - 2030 (USD Million)
Table 113 Kuwait Rare diseases genetic testing market; by specialty; 2018 - 2030 (USD Million)
Table 114 Kuwait Rare diseases genetic testing market; by end use; 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Rare Disease Genetic Testing market: market outlook
Fig. 14 Rare Disease Genetic Testing competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Rare Disease Genetic Testing market driver impact
Fig. 18 Rare Disease Genetic Testing market restraint impact
Fig. 19 Rare Disease Genetic Testing market: Disease movement analysis
Fig. 20 Rare Disease Genetic Testing market: Disease outlook and key takeaways
Fig. 21 Neurological Disorders market estimates and forecast; 2018 - 2030 (USD Million)
Fig. 22 Hematology Diseases market estimates and forecast; 2018 - 2030 (USD Million)
Fig. 23 Endocrine & Metabolism Diseases market estimates and forecast; 2018 - 2030 (USD Million)
Fig. 24 Cancer market estimates and forecast; 2018 - 2030 (USD Million)
Fig. 25 Musculoskeletal Disorders market estimates and forecast; 2018 - 2030 (USD Million)
Fig. 26 Cardiovascular Disorders market estimates and forecast; 2018 - 2030 (USD Million)
Fig. 27 Dermatology Diseases market estimates and forecast; 2018 - 2030 (USD Million)
Fig. 28 Other Rare Diseases market estimates and forecast; 2018 - 2030 (USD Million)
Fig. 29 Rare Disease Genetic Testing market: Technology movement analysis
Fig. 30 Rare Disease Genetic Testing market: Technology outlook and key takeaways
Fig. 31 Next-Generation Sequencing (NGS) market estimates and forecast; 2018 - 2030 (USD Million)
Fig. 32 Whole Exome Sequencing market estimates and forecast; 2018 - 2030 (USD Million)
Fig. 33 Whole Genome Sequencing market estimates and forecast; 2018 - 2030 (USD Million)
Fig. 34 Rare Disease Genetic Testing market: Specialty movement analysis
Fig. 35 Rare Disease Genetic Testing market: Specialty outlook and key takeaways
Fig. 36 Molecular Genetic Tests market estimates and forecast; 2018 - 2030 (USD Million)
Fig. 37 Chromosomal Genetic Tests market estimates and forecast; 2018 - 2030 (USD Million)
Fig. 38 Biochemical Genetic Tests market estimates and forecast; 2018 - 2030 (USD Million)
Fig. 39 Global Rare Disease Genetic Testing market: Regional movement analysis
Fig. 40 Global Rare Disease Genetic Testing market: Regional outlook and key takeaways
Fig. 41 Global Rare Disease Genetic Testing market share and leading players
Fig. 42 North America; by country
Fig. 43 North America market estimates and forecasts; 2018 - 2030 (USD Million)
Fig. 44 U.S. key country dynamics
Fig. 45 U.S. market estimates and forecasts; 2018 - 2030 (USD Million)
Fig. 46 Canada key country dynamics
Fig. 47 Canada market estimates and forecasts; 2018 - 2030 (USD Million)
Fig. 48 Mexico key country dynamics
Fig. 49 Mexico market estimates and forecasts; 2018 - 2030 (USD Million)
Fig. 50 Europe market estimates and forecasts; 2018 - 2030 (USD Million)
Fig. 51 UK key country dynamics
Fig. 52 UK market estimates and forecasts; 2018 - 2030 (USD Million)
Fig. 53 Germany key country dynamics
Fig. 54 Germany market estimates and forecasts; 2018 - 2030 (USD Million)
Fig. 55 France key country dynamics
Fig. 56 France market estimates and forecasts; 2018 - 2030 (USD Million)
Fig. 57 Italy key country dynamics
Fig. 58 Italy market estimates and forecasts; 2018 - 2030 (USD Million)
Fig. 59 Spain key country dynamics
Fig. 60 Spain market estimates and forecasts; 2018 - 2030 (USD Million)
Fig. 61 Denmark key country dynamics
Fig. 62 Denmark market estimates and forecasts; 2018 - 2030 (USD Million)
Fig. 63 Sweden key country dynamics
Fig. 64 Sweden market estimates and forecasts; 2018 - 2030 (USD Million)
Fig. 65 Norway key country dynamics
Fig. 66 Norway market estimates and forecasts; 2018 - 2030 (USD Million)
Fig. 67 Asia Pacific market estimates and forecasts; 2018 - 2030 (USD Million)
Fig. 68 China key country dynamics
Fig. 69 China market estimates and forecasts; 2018 - 2030 (USD Million)
Fig. 70 Japan key country dynamics
Fig. 71 Japan market estimates and forecasts; 2018 - 2030 (USD Million)
Fig. 72 India key country dynamics
Fig. 73 India market estimates and forecasts; 2018 - 2030 (USD Million)
Fig. 74 Thailand key country dynamics
Fig. 75 Thailand market estimates and forecasts; 2018 - 2030 (USD Million)
Fig. 76 South Korea key country dynamics
Fig. 77 South Korea market estimates and forecasts; 2018 - 2030 (USD Million)
Fig. 78 Australia key country dynamics
Fig. 79 Australia market estimates and forecasts; 2018 - 2030 (USD Million)
Fig. 80 Latin America market estimates and forecasts; 2018 - 2030 (USD Million)
Fig. 81 Brazil key country dynamics
Fig. 82 Brazil market estimates and forecasts; 2018 - 2030 (USD Million)
Fig. 83 Argentina key country dynamics
Fig. 84 Argentina market estimates and forecasts; 2018 - 2030 (USD Million)
Fig. 85 Middle East and Africa market estimates and forecasts; 2018 - 2030 (USD Million)
Fig. 86 South Africa key country dynamics
Fig. 87 South Africa market estimates and forecasts; 2018 - 2030 (USD Million)
Fig. 88 Saudi Arabia key country dynamics
Fig. 89 Saudi Arabia market estimates and forecasts; 2018 - 2030 (USD Million)
Fig. 90 UAE key country dynamics
Fig. 91 UAE market estimates and forecasts; 2018 - 2030 (USD Million)
Fig. 92 Kuwait key country dynamics
Fig. 93 Kuwait market estimates and forecasts; 2018 - 2030 (USD Million)
Fig. 94 Market share of key market players - Rare Disease Genetic Testing market